Coeptis Therapeutics, Inc.
COEP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $10,588 | $402,819 | $437,886 | $204,400 |
| - Cash | $533 | $1,469 | $3,791 | $2,180 |
| + Debt | $1,399 | $1,224 | $1,706 | $4,082 |
| Enterprise Value | $11,454 | $402,574 | $435,802 | $206,302 |
| Revenue | $0 | $0 | $0 | $75 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$1,039 | -$1,001 | -$1,001 | $75 |
| % Margin | – | – | – | 100% |
| EBITDA | -$9,443 | -$20,158 | -$36,354 | -$12,815 |
| % Margin | – | – | – | -17,086.3% |
| Net Income | -$10,877 | -$21,267 | -$37,574 | -$13,449 |
| % Margin | – | – | – | -17,932.4% |
| EPS Diluted | -5.65 | -0.83 | -2.87 | -13.16 |
| % Growth | -580.7% | 71.1% | 78.2% | – |
| Operating Cash Flow | -$6,649 | -$7,240 | -$3,876 | -$4,489 |
| Capital Expenditures | $0 | $0 | $0 | -$1,750 |
| Free Cash Flow | -$6,649 | -$7,240 | -$3,876 | -$6,239 |